Ochre Bio

Oxford, United Kingdom

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

$30.0M raised

Oct 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Ochre Bio raised?

Ochre Bio has raised $30.0M in total funding. The most recent round was Series A. The last funding was announced in October 2022.

Who are Ochre Bio's investors?

Ochre Bio's investors include Khosla Ventures, Y Combinator, Apollo Health Ventures, Acequia Capital (AceCap), BACKED VC.

Where is Ochre Bio headquartered?

Ochre Bio is headquartered in Oxford, United Kingdom.

What does Ochre Bio do?

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

What stage is Ochre Bio at?

Ochre Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 10, 2022.

MLA

"Ochre Bio — Funding & Investors." VCBacked, October 10, 2022, https://www.vcbacked.co/company/ochre-bio. Accessed July 2, 2026.

APA

VCBacked. (2022). Ochre Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/ochre-bio

Wikipedia (cite web)

{{cite web |title=Ochre Bio — Funding & Investors |url=https://www.vcbacked.co/company/ochre-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 10, 2022.